• Home
  • Technology
    • The platform
    • Artificial Intelligence
    • BioClick
    • Nobel Prize heritage
    • Biosolution phases
    • Scientific papers
    • Patents
  • Pipeline
    • Pipeline overview
    • NCT: Over-the-Counter
    • NCT: Pharma
    • Cannabinoids
    • Santalene
    • Become a partner
  • Investors
    • Stock information
    • News
    • Email signup
    • Investor Relation Contacts
    • Governance
    • SEC Filings
    • Video
  • About
    • Leadership team
    • History
    • Jobs
    • Contact
  • News
    • Latest news
    • Media coverage
    • Investor news
eXoZymes
Home

Technology

The platform Artificial Intelligence BioClick Scientific papers

Pipeline

Pipeline overview NCT: Over-the-Counter NCT: Pharma Cannabinoids Santalene

Investors

Stock information SEC Filings Email signup

About

About eXoZymes Jobs News
  1. Home

Nasdaq: EXOZ · Video library

Watch the biomanufacturing revolution

Interviews, investor updates and the science behind cell-free production — where chemistry hits its limits and enzymes take over.

Browse the library Investor webinars
Next investor call Register

Latest videos

Webull 'Biotech Sector' webinar by Perriman
interview
Webull 'Biotech Sector' webinar by Perriman June 30, 2026 · 59 views
Podcast: Water Tower Research spotlights EXOZ CEO Heltzen
interview
Podcast: Water Tower Research spotlights EXOZ CEO Heltzen June 29, 2026 · 48 views
Investor Presentation by Chris Marlett (May 2026)
investors
Investor Presentation by Chris Marlett (May 2026) May 11, 2026 · 313 views
eXoZymes Investor Presentation (April 2026)
investors
eXoZymes Investor Presentation (April 2026) April 18, 2026 · 223 views
Grow Everything: NCT as a Superhero?
interview
Grow Everything: NCT as a Superhero? April 13, 2026 · 21 views
Grow Everything: Nature's Secret Unlocked
interview
Grow Everything: Nature's Secret Unlocked April 13, 2026 · 4,792 views
NCT presentation by Damien Perriman, CCO
investors
NCT presentation by Damien Perriman, CCO April 03, 2026 · 153 views
Nasdaq: Damien Perriman interview on NCT
investors
Nasdaq: Damien Perriman interview on NCT April 02, 2026 · 115 views
EXOZ Investor Update - Q4+2025 (March 31. 2026)
investors
EXOZ Investor Update - Q4+2025 (March 31. 2026) April 01, 2026 · 1,250 views
Nasdaq: Michael B. Spector interviews CEO Heltzen
Heltzen's updates
Nasdaq: Michael B. Spector interviews CEO Heltzen March 18, 2026 · 139 views
Interview: Cayman Chemical validates eXoZymes' technology and scalability
investors
Interview: Cayman Chemical validates eXoZymes' technology and scalability March 18, 2026 · 332 views
Rapid Scale-Up: Enzyme Breakthrough Achieved! (01)
investors
Rapid Scale-Up: Enzyme Breakthrough Achieved! (01) March 18, 2026 · 38 views

eXoZymes Inc.

750 Royal Oaks Dr, st 106, 
Monrovia 91016, CA, USA

P: (626) 415-1488
E: info@exozymes.com

 

© eXoZymes Inc. [Nasdaq:EXOZ] unshackling enzymes since 2019 (formerly known as Invizyne Technologies)

Videos Webinars Investors SEC Filings Privacy Policy Terms of Use